Estudo de primeira linha sobre carcinoma esofágico com quimioterapia vs. quimioterapia mais pembrolizumabe
The purpose of this trial is to evaluate efficacy and safety of pembrolizumab plus standard of care (SOC) chemotherapy with cisplatin and 5-fluorouracil (5-FU) versus placebo plus SOC chemotherapy with cisplatin